Rapidly separable microneedle patch for the sustained release of a contraceptive

[1]  J. Kohn.  DMPA self-administration can improve contraceptive access, continuation, and autonomy. , 2018, The Lancet. Global health.

[2]  Guo-Cheng Yuan.  Field-specific reporting , 2018 .

[3]  Xin Pan,et al.  Novel dissolving microneedles for enhanced transdermal delivery of levonorgestrel: In vitro and in vivo characterization. , 2017, International journal of pharmaceutics.

[4]  Zhen Gu,et al.  Locally Induced Adipose Tissue Browning by Microneedle Patch for Obesity Treatment. , 2017, ACS nano.

[5]  Tianwei Yu,et al.  The safety, immunogenicity, and acceptability of inactivated influenza vaccine delivered by microneedle patch (TIV-MNP 2015): a randomised, partly blinded, placebo-controlled, phase 1 trial , 2017, The Lancet.

[6]  Dan Dan Zhu,et al.  Structural optimization of rapidly separating microneedles for efficient drug delivery , 2017 .

[7]  K. Hirota,et al.  Mechanisms of in vivo release of triamcinolone acetonide from PLGA microspheres , 2017, Journal of controlled release : official journal of the Controlled Release Society.

[8]  S. Rafie,et al.  Transdermal delivery of combined hormonal contraception: a review of the current literature , 2017, International journal of women's health.

[9]  B. Whiteside,et al.  Microneedle-assisted transdermal delivery of Zolmitriptan: effect of microneedle geometry, in vitro permeation experiments, scaling analyses and numerical simulations , 2017, Drug development and industrial pharmacy.

[10]  Kinam Park,et al.  PLA micro- and nano-particles. , 2016, Advanced drug delivery reviews.

[11]  Henry Brem,et al.  Polylactic acid (PLA) controlled delivery carriers for biomedical applications. , 2016, Advanced drug delivery reviews.

[12]  Bo Zhi Chen,et al.  Microneedles with Controlled Bubble Sizes and Drug Distributions for Efficient Transdermal Drug Delivery , 2016, Scientific Reports.

[13]  Dan Dan Zhu,et al.  Rapidly separating microneedles for transdermal drug delivery. , 2016, Acta biomaterialia.

[14]  B. R. Johnson,et al.  Abortion incidence between 1990 and 2014: global, regional, and subregional levels and trends , 2016, The Lancet.

[15]  Ryan F. Donnelly,et al.  Microneedle arrays as transdermal and intradermal drug delivery systems: Materials science, manufacture and commercial development , 2016 .

[16]  Zhen Gu,et al.  Microneedles Integrated with Pancreatic Cells and Synthetic Glucose‐Signal Amplifiers for Smart Insulin Delivery , 2016, Advanced materials.

[17]  Mei-Chin Chen,et al.  Near-Infrared Light-Activatable Microneedle System for Treating Superficial Tumors by Combination of Chemotherapy and Photothermal Therapy. , 2016, ACS nano.

[18]  Ichiro Katayama,et al.  Clinical study and stability assessment of a novel transcutaneous influenza vaccination using a dissolving microneedle patch. , 2015, Biomaterials.

[19]  R. Stalter,et al.  Towards the development of a longer-acting injectable contraceptive: past research and current trends. , 2015, Contraception.

[20]  Zhen Gu,et al.  Microneedle-array patches loaded with hypoxia-sensitive vesicles provide fast glucose-responsive insulin delivery , 2015, Proceedings of the National Academy of Sciences.

[21]  Linfeng Wu,et al.  Long-Acting Injectable Hormonal Dosage Forms for Contraception , 2015, Pharmaceutical Research.

[22]  Susheela Singh,et al.  Intended and unintended pregnancies worldwide in 2012 and recent trends. , 2014, Studies in family planning.

[23]  Mark R Prausnitz,et al.  Microneedle patches: usability and acceptability for self-vaccination against influenza. , 2014, Vaccine.

[24]  Gina M. Prescott,et al.  Long‐Acting Reversible Contraception: A Review in Special Populations , 2014, Pharmacotherapy.

[25]  D. Irvine,et al.  Vaccine delivery with microneedle skin patches in nonhuman primates , 2013, Nature Biotechnology.

[26]  Shih-Fang Huang,et al.  Fully embeddable chitosan microneedles as a sustained release depot for intradermal vaccination. , 2013, Biomaterials.

[27]  Paula T Hammond,et al.  Polymer multilayer tattooing for enhanced DNA vaccination. , 2013, Nature materials.

[28]  Gina M A Higginbottom,et al.  “I have to do what I believe”: Sudanese women’s beliefs and resistance to hegemonic practices at home and during experiences of maternity care in Canada , 2013, BMC Pregnancy and Childbirth.

[29]  Paula T Hammond,et al.  Composite Dissolving Microneedles for Coordinated Control of Antigen and Adjuvant Delivery Kinetics in Transcutaneous Vaccination , 2012, Advanced functional materials.

[30]  Jung-Hwan Park,et al.  Microneedles for drug and vaccine delivery. , 2012, Advanced drug delivery reviews.

[31]  Johan Gabrielsson,et al.  Non-compartmental analysis. , 2012, Methods in molecular biology.

[32]  Hirenkumar K. Makadia,et al.  Poly Lactic-co-Glycolic Acid ( PLGA ) as Biodegradable Controlled Drug Delivery Carrier , 2011 .

[33]  Mark R Prausnitz,et al.  Separable arrowhead microneedles. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[34]  Mark R Prausnitz,et al.  Fabrication of dissolving polymer microneedles for controlled drug encapsulation and delivery: Bubble and pedestal microneedle designs. , 2010, Journal of pharmaceutical sciences.

[35]  Seon-Hwa Lee,et al.  Liquid chromatography–mass spectrometry (LC–MS) of steroid hormone metabolites and its applications , 2010, The Journal of Steroid Biochemistry and Molecular Biology.

[36]  Mark R. Prausnitz,et al.  Dissolving Polymer Microneedle Patches for Influenza Vaccination , 2010, Nature Medicine.

[37]  Diana Mansour,et al.  Efficacy of contraceptive methods: A review of the literature , 2010, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

[38]  J. Matriano,et al.  Parathyroid Hormone (1-34)-Coated Microneedle Patch System: Clinical Pharmacokinetics and Pharmacodynamics for Treatment of Osteoporosis , 2010, Pharmaceutical Research.

[39]  Michael S Roberts,et al.  Dry-coated microprojection array patches for targeted delivery of immunotherapeutics to the skin. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[40]  A. Banga,et al.  In vitro transdermal delivery of therapeutic antibodies using maltose microneedles. , 2009, International journal of pharmaceutics.

[41]  A. Morrissey,et al.  Clinical administration of microneedles: skin puncture, pain and sensation , 2009, Biomedical microdevices.

[42]  J. Hardin,et al.  The validity of teens' and young adults' self-reported condom use. , 2009, Archives of pediatrics & adolescent medicine.

[43]  Mark R. Prausnitz,et al.  Effect of Microneedle Design on Pain in Human Volunteers , 2008, The Clinical journal of pain.

[44]  Qiang Zhang,et al.  Synchronic release of two hormonal contraceptives for about one month from the PLGA microspheres: in vitro and in vivo studies. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[45]  Diane J. Burgess,et al.  Evaluation of in vivo-in vitro release of dexamethasone from PLGA microspheres. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[46]  I. Fraser,et al.  Effectiveness of levonorgestrel emergency contraception given before or after ovulation--a pilot study. , 2007, Contraception.

[47]  Mark G. Allen,et al.  Polymer Microneedles for Controlled-Release Drug Delivery , 2006, Pharmaceutical Research.

[48]  S. Zeng,et al.  Controlled release of levonorgestrel from biodegradable poly(D,L-lactide-co-glycolide) microspheres: in vitro and in vivo studies. , 2005, International journal of pharmaceutics.

[49]  Barbara Silverstein,et al.  Estimation of hand force in ergonomic job evaluations , 2005, Ergonomics.

[50]  K. Avgoustakis.  Polylactic-Co-Glycolic Acid ( PLGA ) , 2005 .

[51]  A. R.,et al.  Review of literature , 1951, American Potato Journal.

[52]  Mark R Prausnitz,et al.  Microneedles for transdermal drug delivery. , 2004, Advanced drug delivery reviews.

[53]  Jerry Sullivan,et al.  Review of current literature , 1931, International Urogynecology Journal.

[54]  Lucy Di-Silvio,et al.  Encyclopedia of Biomaterials and Biomedical Engineering. , 2004 .

[55]  I. Sivin.  Risks and Benefits, Advantages and Disadvantages of Levonorgestrel-Releasing Contraceptive Implants , 2003, Drug safety.

[56]  S. Schwendeman,et al.  Characterization of the initial burst release of a model peptide from poly(D,L-lactide-co-glycolide) microspheres. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[57]  J. Natarajan,et al.  Multiple-dose pharmacokinetics of a contraceptive patch in healthy women participants. , 2001, Contraception.

[58]  X Huang,et al.  On the importance and mechanisms of burst release in matrix-controlled drug delivery systems. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[59]  S. Koné,et al.  Safety of immunization injections in Africa: not simply a problem of logistics. , 2000, Bulletin of the World Health Organization.

[60]  E. Hook,et al.  Mechanical failure of the latex condom in a cohort of women at high STD risk. , 1999, Sexually transmitted diseases.

[61]  Chung C. Hsu,et al.  Lyophilization of protein formulations in vials: investigation of the relationship between resistance to vapor flow during primary drying and small-scale product collapse. , 1999, Journal of pharmaceutical sciences.

[62]  D. Mishell,et al.  First week drug concentrations in women with levonorgestrel rod or Norplant capsule implants. , 1997, Contraception.

[63]  M. Shive,et al.  Biodegradation and biocompatibility of PLA and PLGA microspheres , 1997 .

[64]  Anderson,et al.  Biodegradation and biocompatibility of PLA and PLGA microspheres. , 1997, Advanced drug delivery reviews.

[65]  M. Zamorski.  Stroke in users of low-dose oral contraceptives. , 1996, The Journal of family practice.

[66]  S. Sidney,et al.  Stroke in users of low-dose oral contraceptives. , 1996, The New England journal of medicine.

[67]  K. Fotherby.  Levonorgestrel. Clinical pharmacokinetics. , 1995, Clinical pharmacokinetics.

[68]  G. Slap,et al.  The Use of Levonorgestrel Implants (Norplant) for Contraception in Adolescent Mothers , 1994 .

[69]  J. D. Miller,et al.  Lupron depot (leuprolide acetate for depot suspension) in the treatment of endometriosis: a randomized, placebo-controlled, double-blind study. Lupron Study Group. , 1990, Fertility and sterility.

[70]  M. Gibaldi,et al.  Pharmacokinetics, Second Edition , 1982 .